Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

NCT02009332 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-muscle Invasive Bladder Cancer (NMIBC)

Interventions

DRUG: ABI-009
DRUG: Gemcitabine

Sponsor

Aadi Bioscience, Inc.

Collaborators

[object Object]